U.S. flag

An official website of the United States government

NM_000249.4(MLH1):c.1852_1853delinsGC (p.Lys618Ala) AND Hereditary cancer-predisposing syndrome

Germline classification:
Conflicting classifications of pathogenicity (4 submissions)
Last evaluated:
Dec 6, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000130907.23

Allele description [Variation Report for NM_000249.4(MLH1):c.1852_1853delinsGC (p.Lys618Ala)]

NM_000249.4(MLH1):c.1852_1853delinsGC (p.Lys618Ala)

Gene:
MLH1:mutL homolog 1 [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000249.4(MLH1):c.1852_1853delinsGC (p.Lys618Ala)
HGVS:
  • NC_000003.12:g.37047639_37047640delinsGC
  • NG_007109.2:g.59290_59291delinsGC
  • NM_000249.4:c.1852_1853delinsGCMANE SELECT
  • NM_001167617.3:c.1558_1559delinsGC
  • NM_001167618.3:c.1129_1130delinsGC
  • NM_001167619.3:c.1129_1130delinsGC
  • NM_001258271.2:c.1852_1853delinsGC
  • NM_001258273.2:c.1129_1130delinsGC
  • NM_001258274.3:c.1129_1130delinsGC
  • NM_001354615.2:c.1129_1130delinsGC
  • NM_001354616.2:c.1129_1130delinsGC
  • NM_001354617.2:c.1129_1130delinsGC
  • NM_001354618.2:c.1129_1130delinsGC
  • NM_001354619.2:c.1129_1130delinsGC
  • NM_001354620.2:c.1558_1559delinsGC
  • NM_001354621.2:c.829_830delinsGC
  • NM_001354622.2:c.829_830delinsGC
  • NM_001354623.2:c.829_830delinsGC
  • NM_001354624.2:c.778_779delinsGC
  • NM_001354625.2:c.778_779delinsGC
  • NM_001354626.2:c.778_779delinsGC
  • NM_001354627.2:c.778_779delinsGC
  • NM_001354628.2:c.1852_1853delinsGC
  • NM_001354629.2:c.1753_1754delinsGC
  • NM_001354630.2:c.1732-878_1732-877delinsGC
  • NP_000240.1:p.Lys618Ala
  • NP_001161089.1:p.Lys520Ala
  • NP_001161090.1:p.Lys377Ala
  • NP_001161091.1:p.Lys377Ala
  • NP_001245200.1:p.Lys618Ala
  • NP_001245202.1:p.Lys377Ala
  • NP_001245203.1:p.Lys377Ala
  • NP_001341544.1:p.Lys377Ala
  • NP_001341545.1:p.Lys377Ala
  • NP_001341546.1:p.Lys377Ala
  • NP_001341547.1:p.Lys377Ala
  • NP_001341548.1:p.Lys377Ala
  • NP_001341549.1:p.Lys520Ala
  • NP_001341550.1:p.Lys277Ala
  • NP_001341551.1:p.Lys277Ala
  • NP_001341552.1:p.Lys277Ala
  • NP_001341553.1:p.Lys260Ala
  • NP_001341554.1:p.Lys260Ala
  • NP_001341555.1:p.Lys260Ala
  • NP_001341556.1:p.Lys260Ala
  • NP_001341557.1:p.Lys618Ala
  • NP_001341558.1:p.Lys585Ala
  • LRG_216:g.59290_59291delinsGC
  • NC_000003.11:g.37089130_37089131delinsGC
  • NM_000249.3:c.1852_1853delAAinsGC
  • NM_000249.4:c.1852_1853delinsGC
  • NM_001354630.1:c.1732-878_1732-877delinsGC
  • p.K618A
Protein change:
K260A; LYS618ALA
Links:
OMIM: 120436.0012; dbSNP: rs35502531
NCBI 1000 Genomes Browser:
rs35502531
Molecular consequence:
  • NM_001354630.2:c.1732-878_1732-877delinsGC - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000249.4:c.1852_1853delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001167617.3:c.1558_1559delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001167618.3:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001167619.3:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258271.2:c.1852_1853delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258273.2:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258274.3:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354615.2:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354616.2:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354617.2:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354618.2:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354619.2:c.1129_1130delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354620.2:c.1558_1559delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354621.2:c.829_830delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354622.2:c.829_830delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354623.2:c.829_830delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354624.2:c.778_779delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354625.2:c.778_779delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354626.2:c.778_779delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354627.2:c.778_779delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354628.2:c.1852_1853delinsGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354629.2:c.1753_1754delinsGC - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000185816Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Benign
(Dec 6, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV000267048Vantari Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jan 25, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000684775Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Jul 13, 2015)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000788018True Health Diagnostics
no assertion criteria provided
Likely benign
(Jan 3, 2018)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A cell-free assay for the functional analysis of variants of the mismatch repair protein MLH1.

Drost M, Zonneveld Je, van Dijk L, Morreau H, Tops CM, Vasen HF, Wijnen JT, de Wind N.

Hum Mutat. 2010 Mar;31(3):247-53. doi: 10.1002/humu.21180.

PubMed [citation]
PMID:
20020535

Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.

Kosinski J, Hinrichsen I, Bujnicki JM, Friedhoff P, Plotz G.

Hum Mutat. 2010 Aug;31(8):975-82. doi: 10.1002/humu.21301.

PubMed [citation]
PMID:
20533529
PMCID:
PMC2908215
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV000185816.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Vantari Genetics, SCV000267048.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000684775.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From True Health Diagnostics, SCV000788018.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 19, 2025